Siga Technologies INC Costs and Expenses
Siga Technologies INC (SIGA) reported Costs and Expenses of $27.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-06
- Siga Technologies INC costs and expenses for the quarter ending 2026-06-30 was $27.10M, a 23.54% decline year-over-year.
- Siga Technologies INC costs and expenses for the quarter ending 2026-03-31 was $11.56M, a 24.39% increase year-over-year.
- Siga Technologies INC costs and expenses for the quarter ending 2025-12-31 was $13.29M, a 45.48% decline year-over-year.
- Siga Technologies INC costs and expenses for the quarter ending 2025-09-30 was $12.84M, a 35.65% increase year-over-year.
- Siga Technologies INC costs and expenses for fiscal 2025 was $70.87M, a 3.11% increase from fiscal 2024.
- Siga Technologies INC costs and expenses for fiscal 2024 was $68.74M, a 22.10% increase from fiscal 2023.
- Siga Technologies INC costs and expenses for fiscal 2023 was $56.30M, a 17.30% decline from fiscal 2022.
- Siga Technologies INC costs and expenses for fiscal 2022 was $68.08M, a 52.71% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.10M 10-Q · filed 2026-08-06 | $38.66M 10-Q · filed 2026-08-06 | $51.95M derived: sum of 3 quarters · filed 2026-08-06 | $64.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $11.56M 10-Q · filed 2026-05-07 | $24.86M derived: sum of 2 quarters · filed 2026-05-07 | $37.70M derived: sum of 3 quarters · filed 2026-05-07 | $73.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $26.14M derived: sum of 2 quarters · filed 2026-03-10 | $61.58M derived: sum of 3 quarters · filed 2026-08-06 | $70.87M 10-K · filed 2026-03-10 |
| 2025-09-30 | $12.84M 10-Q · filed 2025-11-06 | $48.28M derived: sum of 2 quarters · filed 2026-08-06 | $57.58M 10-Q · filed 2025-11-06 | $81.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $35.44M 10-Q · filed 2026-08-06 | $44.74M 10-Q · filed 2026-08-06 | $69.12M derived: sum of 3 quarters · filed 2026-08-06 | $78.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.30M 10-Q · filed 2026-05-07 | $33.68M derived: sum of 2 quarters · filed 2026-05-07 | $43.15M derived: sum of 3 quarters · filed 2026-05-07 | $63.88M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $24.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $33.85M derived: sum of 2 quarters · filed 2026-03-10 | $54.58M derived: sum of 3 quarters · filed 2026-03-10 | $68.74M 10-K · filed 2026-03-10 |
| 2024-09-30 | $9.47M 10-Q · filed 2025-11-06 | $30.20M derived: sum of 2 quarters · filed 2025-11-06 | $44.35M 10-Q · filed 2025-11-06 | $69.16M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $20.73M 10-Q · filed 2025-08-05 | $34.89M 10-Q · filed 2025-08-05 | $59.69M derived: sum of 3 quarters · filed 2026-03-10 | $70.23M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $14.15M 10-Q · filed 2025-05-08 | $38.96M derived: sum of 2 quarters · filed 2026-03-10 | $49.50M derived: sum of 3 quarters · filed 2026-03-10 | $60.02M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $24.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $35.35M derived: sum of 2 quarters · filed 2026-03-10 | $45.86M derived: sum of 3 quarters · filed 2026-03-10 | $56.30M 10-K · filed 2026-03-10 |
| 2023-09-30 | $10.54M 10-Q · filed 2024-11-07 | $21.06M derived: sum of 2 quarters · filed 2024-11-07 | $31.49M 10-Q · filed 2024-11-07 | $44.66M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $10.52M 10-Q · filed 2024-08-01 | $20.95M 10-Q · filed 2024-08-01 | $34.11M derived: sum of 3 quarters · filed 2025-03-11 | $63.45M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $10.43M 10-Q · filed 2024-05-07 | $23.59M derived: sum of 2 quarters · filed 2025-03-11 | $52.93M derived: sum of 3 quarters · filed 2025-03-11 | $66.53M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $13.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $42.50M derived: sum of 2 quarters · filed 2025-03-11 | $56.10M derived: sum of 3 quarters · filed 2025-03-11 | $68.08M 10-K · filed 2025-03-11 |
| 2022-09-30 | $29.34M 10-Q · filed 2023-11-07 | $42.93M derived: sum of 2 quarters · filed 2023-11-07 | $54.91M 10-Q · filed 2023-11-07 | $76.24M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | $13.60M 10-Q · filed 2023-08-08 | $25.57M 10-Q · filed 2023-08-08 | $46.91M derived: sum of 3 quarters · filed 2024-03-12 | $54.70M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | $11.98M 10-Q · filed 2023-05-04 | $33.31M derived: sum of 2 quarters · filed 2024-03-12 | $41.10M derived: sum of 3 quarters · filed 2024-03-12 | $49.75M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | $21.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $29.12M derived: sum of 2 quarters · filed 2024-03-12 | $37.77M derived: sum of 3 quarters · filed 2024-03-12 | $44.58M 10-K · filed 2024-03-12 |
| 2021-09-30 | $7.79M 10-Q · filed 2022-11-03 | $16.44M derived: sum of 2 quarters · filed 2022-11-03 | $23.25M 10-Q · filed 2022-11-03 | $34.17M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $8.65M 10-Q · filed 2022-08-04 | $15.46M 10-Q · filed 2022-08-04 | $26.38M derived: sum of 3 quarters · filed 2023-03-02 | $37.74M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $6.80M 10-Q · filed 2022-05-05 | $17.73M derived: sum of 2 quarters · filed 2023-03-02 | $29.09M derived: sum of 3 quarters · filed 2023-03-02 | $40.64M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $10.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $22.29M derived: sum of 2 quarters · filed 2023-03-02 | $33.84M derived: sum of 3 quarters · filed 2023-03-02 | $40.46M 10-K · filed 2023-03-02 |
| 2020-09-30 | $11.36M 10-Q · filed 2021-11-04 | $22.91M derived: sum of 2 quarters · filed 2021-11-04 | $29.53M 10-Q · filed 2021-11-04 | $37.27M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $11.55M 10-Q · filed 2021-08-05 | $18.17M 10-Q · filed 2021-08-05 | $25.90M derived: sum of 3 quarters · filed 2022-03-03 | $33.35M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $6.62M 10-Q · filed 2021-05-06 | $14.35M derived: sum of 2 quarters · filed 2022-03-03 | $21.80M derived: sum of 3 quarters · filed 2022-03-03 | $27.41M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $15.18M derived: sum of 2 quarters · filed 2022-03-03 | $20.80M derived: sum of 3 quarters · filed 2022-03-03 | $29.06M 10-K · filed 2022-03-03 |
| 2019-09-30 | $7.45M 10-Q · filed 2020-11-05 | $13.06M derived: sum of 2 quarters · filed 2020-11-05 | $21.33M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $5.61M 10-Q · filed 2020-08-06 | $13.88M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $8.27M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $121.95M 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |